Followers

December 21, 2023

US FDA approves Sweden-based Calliditas' kidney disease drug

The U.S. Food and Drug Administration (FDA) granted full approval to Swedish drugmaker Calliditas Therapeutics' drug to treat rare kidney disease IgA Nephropathy (IgAN), the company said on Wednesday.

No comments:

Post a Comment